Clinical significance of c-erbB2 oncoprotein expression in stomach carcinoma
Gong, Z.; Luo, E.; Lu, Q.
Zhonghua Zhong Liu Za Zhi 18(4): 299-301
1996
ISSN/ISBN: 0253-3766 PMID: 9387327 Document Number: 463131
This paper reports a study of the c-erbB2 oncoprotein (by immunohistochemical method) in 97 gastric carcinoma resected at Shanghai Cancer Hospital in 1991. In 30 out of the 97 cases (30.9%) c-erbB2 was positive and its expression was higher among patients with lymph node metastasis (P < 0.05). Univariate and multivariate analyses indicated that c-erbB2 expression betokened poor prognosis.
Document emailed within 1 workday
Related Documents
Yonemura, Y.; Ninomiya, I.; Tsugawa, K.; Fushida, S.; Fujimura, T.; Miyazaki, I.; Uchibayashi, T.; Endou, Y.; Sasaki, T. 1998: Prognostic significance of c-erbB-2 gene expression in the poorly differentiated type of adenocarcinoma of the stomach Cancer Detection and Prevention 22(2): 139-146Horiguchi, J.; Iino, Y.; Takei, H.; Yokoe, T.; Ishida, T.; Morishita, Y. 1993: Immunohistochemical study on the expression of c-erbB-2 oncoprotein in breast cancer Oncology 51(1): 47-51
Suwanagool, P.; Parichatikanond, P.; Maeda, S. 1993: Expression of c-erbB-2 oncoprotein in primary human tumors: an immunohistochemistry study Asian Pacific Journal of Allergy and Immunology 11(2): 119-122
Wright, C.; Angus, B.; Nicholson, S.; Sainsbury, J.R.; Cairns, J.; Gullick, W.J.; Kelly, P.; Harris, A.L.; Horne, C.H. 1989: Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer Cancer Research 49(8): 2087-2090
Edorh, A.; Parache, R.M.; Migeon, C.; N'Sossani, B.; Rihn, B. 1995: Expression of the c-erbB-2 oncoprotein in mammary Paget's disease. Immunohistochemical study by using 3 antibodies Pathologie-Biologie 43(7): 584-589
Aryandono, T.; Harijadi; Ghozali, A. 2000: Correlation of clinical, pathological status, hormone receptor and C-erbB-2 oncoprotein in breast cancer patients Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 600-606
Gosney, J.R.; Field, J.K.; Gosney, M.A.; Lye, M.D.; Spandidos, D.A.; Butt, S.A. 1990: C-myc oncoprotein in bronchial carcinoma: expression in all major morphological types Anticancer Research 10(3): 623-628
Suthipintawong, C.; Wejaranayang, C.; Vipupinyo, C. 2008: Prognostic significance of ER, PR, Ki67, c-erbB-2, and p53 in endometrial carcinoma Journal of the Medical Association of Thailand 91(12): 1779-1784
EI-Emshaty, H.M.; Saad, E.A.; Toson, E.A.; Abdel Malak, C.A.; Gadelhak, N.A. 2014: Apoptosis and cell proliferation: correlation with BCL-2 and P53 oncoprotein expression in human hepatocellular carcinoma Hepato-Gastroenterology 61(133): 1393-1401
Lee, E.Y.; Cibull, M.L.; Strodel, W.E.; Haley, J.V. 1994: Expression of HER-2/neu oncoprotein and epidermal growth factor receptor and prognosis in gastric carcinoma Archives of Pathology and Laboratory Medicine 118(3): 235-239
Craven, J.M.; Pavelic, Z.P.; Stambrook, P.J.; Pavelic, L.; Gapany, M.; Kelley, D.J.; Gapany, S.; Gluckman, J.L. 1992: Expression of c-erbB-2 gene in human head and neck carcinoma Anticancer Research 12(6b): 2273-2276
Regidor, P.A.; Callies, R.; Schindler, A.E. 1995: Level of c-erbB-2 oncoprotein in the homogenate of malignant and benign breast tumor samples European Journal of Gynaecological Oncology 16(2): 130-137
Xu, Z.; Chen, X.; Peng, C.; Liu, E.; Li, Y.; Li, C.; Niu, J. 2013: The expression and clinical significance of Omi/Htra2 in hepatocellular carcinoma Hepato-Gastroenterology 60(121): 6-13
Xu, X.; Yuan, G.; Liu, W.; Zhang, Y.; Chen, W. 2009: Expression of cathepsin L in nasopharyngeal carcinoma and its clinical significance Experimental Oncology 31(2): 102-105
Offterdinger, M.; Schneider, S.M.; Huber, H.; Grunt, T.W. 1999: Expression of c-erbB-4/HER4 is regulated in T47D breast carcinoma cells by retinoids and vitamin D3 Biochemical and Biophysical Research Communications 258(3): 559-564
Schimmelpenning, H.; Eriksson, E.T.; Pallis, L.; Skoog, L.; Cedermark, B.; Auer, G.U. 1992: Immunohistochemical c-erbB-2 protooncogene expression and nuclear DNA content in human mammary carcinoma in situ American Journal of Clinical Pathology 97(5 Suppl 1: S48-S52
Kniazev, P.G.; Imianitov, E.N.; Chernitsa, O.I.; Nikiforova, I.F.; Babenko, V.I.; Bruderliaĭn, S.; Plutalo, O.V.; Kuz'min, A.I.; Kaboev, O.K.; Berlin, I.A. 1992: Complex characteristics of the alterations of oncogenes HER-2/ERBB-2, HER-1/ERBB-1, HRAS-1, C-MYC and antioncogenes p53, RB1, as well as deletions of loci of chromosome 17 in colon carcinoma Molekuliarnaia Biologiia 26(5): 1134-1147
Yu, M.W.; Chen, C.J.; Luo, J.C.; Brandt-Rauf, P.W.; Carney, W.P.; Santella, R.M. 1994: Correlations of chronic hepatitis B virus infection and cigarette smoking with elevated expression of neu oncoprotein in the development of hepatocellular carcinoma Cancer Research 54(19): 5106-5110
Liang, C.; Xu, G. 1999: Nm23-H1 protein expression and its clinical significance in human laryngeal carcinoma Hua Xi Yi Ke da Xue Xue Bao 30(4): 391-393
Zhang, Y.; Liu, Y.-P.; Du, K.; Wang, H.; Wang, X.-L. 2011: Expression and clinical significance of PI3K in esophageal squamous cell carcinoma Zhonghua Zhong Liu Za Zhi 33(8): 594-598